Literature DB >> 25033798

The Ras superfamily G-proteins.

Ashley L Tetlow1, Fuyuhiko Tamanoi2.   

Abstract

The Ras superfamily G-proteins are monomeric proteins of approximately 21kDa that act as a molecular switch to regulate a variety of cellular processes. The structure of the Ras superfamily G-proteins, their regulators as well as posttranslational modification of these proteins leading to their membrane association have been elucidated. The Ras superfamily G-proteins interact at their effector domains with their downstream effectors via protein-protein interactions. Mutational activation or overexpression of the Ras superfamily G-proteins has been observed in a number of human cancer cases. Over the years, a variety of approaches to inhibit the Ras superfamily G-proteins have been developed. These different approaches are discussed in this volume.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arf; Crystal structure; Effectors; G-motifs; GAP; GEF; Membrane association; NMR structure; Posttranslational modification; Rab; Ran; Ras; Ras superfamily G-proteins; Rho

Mesh:

Substances:

Year:  2013        PMID: 25033798     DOI: 10.1016/B978-0-12-416749-0.00001-4

Source DB:  PubMed          Journal:  Enzymes        ISSN: 1874-6047


  6 in total

1.  Fine-Tuning of the Actin Cytoskeleton and Cell Adhesion During Drosophila Development by the Unconventional Guanine Nucleotide Exchange Factors Myoblast City and Sponge.

Authors:  Bridget Biersmith; Zong-Heng Wang; Erika R Geisbrecht
Journal:  Genetics       Date:  2015-04-23       Impact factor: 4.562

2.  Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6.

Authors:  Qiuyan Liu; Ha Zhu; Chaoxiong Zhang; Taoyong Chen; Xuetao Cao
Journal:  Oncoimmunology       Date:  2016-12-23       Impact factor: 8.110

3.  HRAS-driven cancer cells are vulnerable to TRPML1 inhibition.

Authors:  Jewon Jung; Kwang-Jin Cho; Ali K Naji; Kristen N Clemons; Ching On Wong; Mariana Villanueva; Steven Gregory; Nicholas E Karagas; Lingxiao Tan; Hong Liang; Morgan A Rousseau; Kelly M Tomasevich; Andrew G Sikora; Ilya Levental; Dharini van der Hoeven; Yong Zhou; John F Hancock; Kartik Venkatachalam
Journal:  EMBO Rep       Date:  2019-02-20       Impact factor: 8.807

4.  Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143.

Authors:  Yukihiro Akao; Minami Kumazaki; Haruka Shinohara; Nobuhiko Sugito; Yuki Kuranaga; Takuya Tsujino; Yuki Yoshikawa; Yukio Kitade
Journal:  Cancer Sci       Date:  2018-04-14       Impact factor: 6.716

5.  Computational Analysis of Deleterious SNPs in NRAS to Assess Their Potential Correlation With Carcinogenesis.

Authors:  Mohammed Y Behairy; Mohamed A Soltan; Mohamed S Adam; Ahmed M Refaat; Ehab M Ezz; Sarah Albogami; Eman Fayad; Fayez Althobaiti; Ahmed M Gouda; Ashraf E Sileem; Mahmoud A Elfaky; Khaled M Darwish; Muhammad Alaa Eldeen
Journal:  Front Genet       Date:  2022-08-16       Impact factor: 4.772

Review 6.  KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target.

Authors:  Marta Román; Iosune Baraibar; Inés López; Ernest Nadal; Christian Rolfo; Silvestre Vicent; Ignacio Gil-Bazo
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 41.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.